Premium
Royalty Pharma PLC (RPRX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Capital Research and Management Company | Institution | 45 809 133 | 10,33% | US$ 2,54B | 2026-03-31 |
| Morgan Stanley Investment Management Inc. | Institution | 36 931 108 | 8,33% | US$ 2,04B | 2026-03-31 |
| BlackRock, Inc. | Institution | 25 907 623 | 5,84% | US$ 1,43B | 2026-03-31 |
| Mr. Mario Giuliani | Initiés | 21 366 927 | 4,82% | US$ 1,18B | 2026-06-12 |
| FMR LLC | Institution | 19 345 396 | 4,36% | US$ 1,07B | 2026-03-31 |
| Baillie Gifford & Co. | Institution | 16 155 677 | 3,64% | US$ 894,22M | 2026-03-31 |
| Swedbank Robur Fonder AB | Institution | 11 586 693 | 2,61% | US$ 641,32M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 10 989 851 | 2,48% | US$ 608,29M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 7 869 632 | 1,78% | US$ 435,58M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 7 480 633 | 1,69% | US$ 414,05M | 2026-03-31 |
| Caledonia (Private) Investments Pty Limited | Institution | 7 168 399 | 1,62% | US$ 396,77M | 2026-03-31 |
| Strategic Advisers LLC | Institution | 5 806 846 | 1,31% | US$ 321,41M | 2026-03-31 |
| UBS Asset Management AG | Institution | 4 907 969 | 1,11% | US$ 271,66M | 2026-03-31 |
| Mr. Pablo Legorreta | Initiés | 4 846 979 | 1,09% | US$ 268,28M | 2026-05-06 |
| Vanguard Capital Management, LLC | Institution | 4 531 886 | 1,02% | US$ 250,84M | 2026-03-31 |
| Victory Capital Management Inc. | Institution | 3 853 808 | 0,87% | US$ 213,31M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 3 808 735 | 0,86% | US$ 210,81M | 2026-03-31 |
| Royal London Asset Management Ltd. | Institution | 3 808 353 | 0,86% | US$ 210,79M | 2026-03-31 |
| AQR Capital Management, LLC | Institution | 3 705 957 | 0,84% | US$ 205,12M | 2026-03-31 |
| Patient Capital Management, LLC | Institution | 3 643 716 | 0,82% | US$ 201,68M | 2026-03-31 |
| Morgan Stanley | Institution | 3 476 436 | 0,78% | US$ 192,42M | 2026-03-31 |
| Norges Bank Investment Management | Institution | 3 414 165 | 0,77% | US$ 188,97M | 2025-12-31 |
| Legal & General Investment Management Limited | Institution | 3 362 872 | 0,76% | US$ 186,13M | 2026-03-31 |
| Eaton Vance Management | Institution | 3 164 406 | 0,71% | US$ 175,15M | 2026-03-31 |
| Amundi Asset Management SAS | Institution | 3 090 087 | 0,70% | US$ 171,04M | 2026-03-31 |
| Capital Advisor Network | Institution | 3 030 974 | 0,68% | US$ 167,76M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 3 027 899 | 0,68% | US$ 167,59M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 2 681 069 | 0,60% | US$ 148,40M | 2026-03-31 |
| Invesco Ltd. | Institution | 2 628 574 | 0,59% | US$ 145,49M | 2026-03-31 |
| NewSouth Capital Management, Inc. | Institution | 2 625 863 | 0,59% | US$ 145,34M | 2026-03-31 |
| Deutsche Asset & Wealth Management | Institution | 2 405 294 | 0,54% | US$ 133,13M | 2026-03-31 |
| Jane Street Group, LLC | Institution | 2 400 382 | 0,54% | US$ 132,86M | 2026-03-31 |
| Dorsey Asset Management LLC | Institution | 2 276 570 | 0,51% | US$ 126,01M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 2 268 811 | 0,51% | US$ 125,58M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 2 251 525 | 0,51% | US$ 124,62M | 2026-03-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 2 187 695 | 0,49% | US$ 121,09M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
